PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Mount Sinai review maps the path forward for cancer vaccines, highlighting promise of personalized and combination approaches

2026-01-22
(Press-News.org) NEW YORK, (January 22, 2026) – A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, and effective immunotherapies, particularly when combined with other cancer treatments.

The review, titled “Pipe Dream to Pipeline: Journey of Cancer Vaccines and the Road Ahead” and published in Cell Reports Medicine, examines the evolution of therapeutic cancer vaccines, with a special focus on neoantigen-based vaccines—highly personalized vaccines designed using genetic mutations unique to a patient’s tumor.

“Cancer vaccines were once seen as a promising idea that struggled to deliver durable clinical benefit,” said Nina Bhardwaj, MD, PhD, senior author of the review, Ward-Coleman Chair in Cancer Research, and Director of the Vaccine and Cell Therapy Laboratory at the Icahn School of Medicine at Mount Sinai, and Co-Director of the Cancer Immunology Program at the Mount Sinai Tisch Cancer Center. “Today, advances in sequencing, immune profiling, and vaccine platforms are transforming that landscape and opening the door to more effective, long-lasting immune responses against cancer.”

While early cancer vaccines showed limited success as standalone treatments, the review highlights how modern technologies have revitalized the field. Improvements in tumor sequencing and a deeper understanding of the tumor microenvironment have enabled researchers to identify precise immune targets and design vaccines that better activate cancer-fighting T cells.

Clinical trial data summarized in the review show that personalized neoantigen vaccines (delivered as peptides, DNA, or mRNA) are safe and capable of generating robust immune responses across a range of cancers, including melanoma, pancreatic cancer, glioblastoma, lung cancer, and bladder cancer.

Importantly, the authors note growing evidence that cancer vaccines may be most effective when used in combination with immune checkpoint inhibitors and other standard therapies, helping overcome immune resistance and improve patient outcomes.

The review synthesizes decades of clinical research and identifies key reasons earlier cancer vaccines fell short, including immune suppression within tumors and limitations in antigen selection. It also outlines persistent challenges, such as the time and cost required to manufacture personalized vaccines and the need for better biomarkers to predict response.

At the same time, the authors highlight emerging strategies, such as shared “off-the-shelf” neoantigen vaccines and improved vaccine delivery platforms, that could expand access and accelerate clinical use.

By drawing together insights from past and ongoing clinical trials, the review outlines a road map for integrating cancer vaccines into standard-of-care treatment, particularly in early-stage disease and in combination with other immunotherapies.

The authors emphasize that while most cancer vaccine clinical trials to date have been early-phase studies, larger randomized clinical trials will be critical to defining how these therapies can best improve survival and quality of life for patients.

“Pipe Dream to Pipeline: Journey of Cancer Vaccines and the Road Ahead” was authored by Sayali Onkar, PhD, under the guidance of Dr. Bhardwaj along with investigators Cansu Cimen Bozkus, PhD, and Mansi Saxena, PhD, from the Vaccine and Cell Therapy Laboratory and the Division of Hematology and Oncology at the Mount Sinai Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, with collaborators from the Parker Institute for Cancer Immunotherapy.

###
 

About the Icahn School of Medicine at Mount Sinai 

The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the seven member hospitals* of the Mount Sinai Health System, one of the largest academic health systems in the United States, providing care to New York City’s large and diverse patient population. 

 

The Icahn School of Medicine at Mount Sinai offers highly competitive MD, PhD, MD-PhD, and master’s degree programs, with enrollment of more than 1,200 students. It has the largest graduate medical education program in the country, with more than 2,600 clinical residents and fellows training throughout the Health System. Its Graduate School of Biomedical Sciences offers 13 degree-granting programs, conducts innovative basic and translational research, and trains more than 560 postdoctoral research fellows. 

 

Ranked 11th nationwide in National Institutes of Health (NIH) funding, the Icahn School of Medicine at Mount Sinai is among the 99th percentile in research dollars per investigator according to the Association of American Medical Colleges.  More than 4,500 scientists, educators, and clinicians work within and across dozens of academic departments and multidisciplinary institutes with an emphasis on translational research and therapeutics. Through Mount Sinai Innovation Partners (MSIP), the Health System facilitates the real-world application and commercialization of medical breakthroughs made at Mount Sinai.

------------------------------------------------------- 

* Mount Sinai Health System member hospitals: The Mount Sinai Hospital; Mount Sinai Brooklyn; Mount Sinai Morningside; Mount Sinai Queens; Mount Sinai South Nassau; Mount Sinai West; and New York Eye and Ear Infirmary of Mount Sinai.  

END



ELSE PRESS RELEASES FROM THIS DATE:

Illinois study: How a potential antibiotics ban could affect apple growers

2026-01-22
URBANA, Ill. – Antibiotic resistance in human and animal health is on the forefront of public debate, but it’s a less well-known issue in plant agriculture. However, antibiotics are important tools in fruit production, and their efficacy hinges on avoiding resistance in disease-causing bacteria.  The U.S. does not currently restrict antibiotics use in fruit orchards, but regulatory measures could occur in the future. A new study from the University of Illinois Urbana-Champaign ...

UC Irvine and Jefferson Health researchers find differences between two causes of heart valve narrowing

2026-01-22
Irvine, Calif., Jan. 22, 2026 — University of California, Irvine and Philadelphia-based Jefferson Health researchers have identified fundamental structural and functional differences between two major causes of mitral valve stenosis. This narrowing restricts blood flow through the heart. The findings challenge current diagnostic approaches and may help clinicians tailor treatment decisions for a growing patient population. The study, published in the Journal of the American Heart Association, combined 3D ultrasound heart imaging ...

Ancien DNA pushes back record of treponemal disease-causing bacteria by 3,000 years

2026-01-22
Scientists have recovered a genome of Treponema pallidum – the bacterium whose subspecies today are responsible for four treponemal diseases, including syphilis – from 5,500-year-old human remains in Sabana de Bogotá, Colombia. The research expands knowledge about the history of this infectious disease and its occurrence in human populations, with findings now published in the journal Science.    The individual was archaeologically recovered from a rock shelter near Bogotá, Colombia, dating back roughly 5,500 years. The discovery pushes the genetic record of this pathogenic ...

Human penis size influences female attraction and male assessment of rivals

2026-01-22
Men assess potential rivals that have a larger penis as more of a threat, both physically and sexually, according to a study by Upama Aich at the University of Western Australia and colleagues, publishing January 22nd in the open-access journal PLOS Biology. Relative to body size, the human penis is larger than that of other primates, a fact that has puzzled evolutionary biologists. Before the invention of clothing, the penis would have been a prominent feature that might influence potential mates and ...

Scientists devise way to track space junk as it falls to earth

2026-01-22
Space debris—the thousands of pieces of human-made objects abandoned in Earth’s orbit—pose a risk to humans when they fall to the ground. To locate possible crash sites, a Johns Hopkins University scientist has helped to devise a way to track falling debris using existing networks of earthquake-detecting seismometers.  The new tracking method generates more detailed information in near real-time than authorities have today—information that will help to quickly locate and retrieve the charred and sometimes toxic remains.  “Re-entries are happening more frequently. Last year, we had multiple satellites entering our atmosphere ...

AI is already writing almost one-third of new software code

2026-01-22
Generative AI is reshaping software development – and fast. A new study published in Science shows that AI-assisted coding is spreading rapidly, though unevenly: in the U.S., the share of new code relying on AI rose from 5% in 2022 to 29% in early 2025, compared with just 12% in China. AI usage is highest among less experienced programmers, but productivity gains go to seasoned developers. The software industry is enormous. In the U.S. economy alone, firms spend an estimated $600 billion a year in wages on coding-related work. Every day, billions of lines of code keep the global economy running. How is AI changing this backbone of modern ...

A 5,500-year-old genome rewrites the origins of syphilis

2026-01-22
A newly sequenced genome of the bacterium that causes syphilis, Treponema pallidum, highlights the deep antiquity of treponemal diseases in the Americas. The findings, based on a 5,500-year-old specimen from Colombia, suggest syphilis’s emergence was not dependent on the agricultural intensification and population crowding often linked to the spread of infectious disease. Instead, it was dependent on social and ecological conditions of hunter-gatherer societies. “Reframing syphilis, alongside other infectious diseases, as products of both localized and highly specific ...

Tracking uncontrolled space debris reentry using sonic booms

2026-01-22
Researchers present a novel way to track errant space debris as it falls to Earth in near-real-time, according to a new study. Their method uses ground-based seismic sensors. Over the last several years, the number of spent spacecraft and other debris reentering Earth’s atmosphere has grown exponentially. These uncontrolled reentries pose increasing risks to human life, infrastructure, and the environment. As Earth’s orbit grows increasingly crowded and reentries become more frequent – potentially involving spacecraft carrying toxic, flammable, or radioactive materials – these risks are expected to become more of ...

Endogenous retroviruses promote early human zygotic development

2026-01-22
New findings offer insight into why some embryos fail to develop past zygotic genome activation (ZGA), pointing to an unexpected root of human infertility. A critical point in early development is zygotic genome activation (ZGA), a milestone that marks the transition from reliance on maternal factors to activation of its own genome. This process requires a comprehensive reshaping of chromatin and transcription networks. Failures in ZGA are a major cause of early embryo arrest and contribute to cases of infertility and pregnancy loss. Previous research has shown that endogenous retroviruses (ERVs) – genetic remnants of ancient viral infections ...

Malicious AI swarms pose emergent threats to democracy

2026-01-22
In a Policy Forum, Daniel Schroeder and colleagues discuss the risks of malicious “Artificial Intelligence (AI) swarms”, which enable a new class of large-scale, coordinated disinformation campaigns that pose significant risks to democracy. Manipulation of public opinion has long relied on rhetoric and propaganda. However, modern AI systems have created powerful new tools for shaping human beliefs and behavior on a societal scale. Large language models (LLMs) and autonomous agents can now generate vast amounts of persuasive, human-like content. When combined into collaborative AI Swarms – collections of AI-driven personas that retain memory and identity – ...

LAST 30 PRESS RELEASES:

National Foundation for Cancer Research CEO Sujuan Ba Named One of OncoDaily’s 100 Most Influential Oncology CEOs of 2025

New analysis disputes historic earthquake, tsunami and death toll on Greek island

Drexel study finds early intervention helps most autistic children acquire spoken language

Study finds Alzheimer's disease can be evaluated with brain stimulation

Cells that are not our own may unlock secrets about our health

Caring Cross and Boston Children’s Hospital collaborate to expand access to gene therapy for sickle cell disease and beta thalassemia

Mount Sinai review maps the path forward for cancer vaccines, highlighting promise of personalized and combination approaches

Illinois study: How a potential antibiotics ban could affect apple growers

UC Irvine and Jefferson Health researchers find differences between two causes of heart valve narrowing

Ancien DNA pushes back record of treponemal disease-causing bacteria by 3,000 years

Human penis size influences female attraction and male assessment of rivals

Scientists devise way to track space junk as it falls to earth

AI is already writing almost one-third of new software code

A 5,500-year-old genome rewrites the origins of syphilis

Tracking uncontrolled space debris reentry using sonic booms

Endogenous retroviruses promote early human zygotic development

Malicious AI swarms pose emergent threats to democracy

Progenitor cells in the brain constantly attempt to produce new myelin-producing brain cells

Quantum measurements with entangled atomic clouds

Mayo Clinic researchers use AI to predict patient falls based on core density in middle age

Moffitt study develops new tool to predict how cancer evolves

National Multiple Sclerosis Society awards Dr. Manuel A. Friese the 2025 Barancik Prize for Innovation in MS Research

PBM profits obscured by mergers and accounting practices, USC Schaeffer white paper shows

Breath carries clues to gut microbiome health

New study links altered cellular states to brain structure

Palaeontology: Ancient giant kangaroos could hop to it when they needed to

Decoded: How cancer cells protect themselves from the immune system

ISSCR develops roadmap to accelerate pluripotent stem cell-derived therapies to patients

New study shows gut microbiota directly regulates intestinal stem cell aging

Leading cancer deaths in people younger than 50 years

[Press-News.org] Mount Sinai review maps the path forward for cancer vaccines, highlighting promise of personalized and combination approaches